UPDATE: Barclays Initiates Coverage On United Therapeutics

By: via Benzinga
United Therapeutics Corporation (NASDAQ: UTHR) is facing patent expirations, increasing competition and an uncertain pipeline of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.